Industry:
Client:
Solution:
NervGen, a publicly traded clinical-stage biotech company based in Vancouver, collaborated with our agency to develop a new website that reflects its clinical stage and strategic focus. Its new digital presence features updated modern branding, along with an updated design, improving its usability, messaging, and strategic direction.
They hired our digital agency to lead a full brand evolution alongside their website redesign, at a moment when the company was facing more opportunity than ever before. Their team knew their existing site no longer matched the stage of the company they had become.
Their team had a specific challenge with their existing logo. They wanted an evolution rather than a full rebrand, something that kept enough familiarity for their growing investor base while giving the brand a flexible, standalone mark to build around.
Beyond the visual identity, NervGen needed their new website to do something their old one never had: properly explain what spinal cord injury actually looks like. The site needed to speak to patients and advocates, and investors all at once, without losing credibility with any of them.
The NervGen team was involved at every stage, meeting with our design team to review logo concepts, homepage directions, and page content. Rather than jumping straight to a website, our team began with a true brand evolution: exploring a wide range of logo directions.
Color played a central role in evolution. Our designer introduced a more saturated, intentional palette alongside a new typography system, giving the brand room to grow well beyond the logo itself. For the website, the team moved toward a dark, deep blue background paired with a subtle highlighter-yellow accent, used sparingly for buttons and hover states. The combination gave the site a more modern, high-impact feel while still conveying the sense of calm the NervGen team wanted their site to reflect.
That extension went well beyond color. Arrows, circles, and masking shapes pulled directly from the new logo’s geometry became recurring visual motifs, reinforcing the brand in places a static logo never could.
The homepage was designed to work as a visual table of contents, leading with NervGen‘s origin story and decades of research before moving into the science, the pipeline, and the company’s ongoing clinical trial. Our team also worked closely with NervGen to navigate one of the project’s most sensitive design decisions: how to represent people living with spinal cord injury without reducing their experience to a single image. The team explored ways to represent the full range of what spinal cord injury (SCI) looks like day to day.
Our teams worked together to build out a dedicated page explaining what it means to live with tetraplegia, giving both patients and investors a clearer understanding of the condition NervGen‘s therapy targets.
The result is a website that builds investor and patient trust. It positions NervGen as a public clinical-stage biotechnology company. The website makes their story easier for investors, physicians, patients, and partners to understand.
The new NervGen website includes:
The redesigned website gives NervGen a platform to communicate its investors, clinical progress and long-term vision. It creates an engaging experience for every visitor to the NervGen website.
